Fingerprint
Dive into the research topics of 'Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer
Haiyang Chen, Kazuhiko Shien, Ken Suzawa, Kazunori Tsukuda, Shuta Tomida, Hiroki Sato, Hidejiro Torigoe, Mototsugu Watanabe, Kei Namba, Hiromasa Yamamoto, Junichi Sou, Hiroaki Asano, Shinichiro Miyoshi, Shinichi Toyooka
Research output: Contribution to journal › Article › peer-review
10
Citations
(Scopus)